In melanoma cells, activation of the WNT/Β-catenin pathway reduces the number of tumor-infiltrating lymphocytes (TILs) because activation of this pathway decreases the expression of chemokine C-C motif ligand 4 (CCL4), which is essential for tumor infiltration by DCs. Here, CCL4 is linked to melanoma.